How Testosterone Works and Hypogonadism in Males with Dr. Scott Howell #369

2023-12-21

This conversation is not your average discussion about testosterone; it's a journey into the physiological pathways, the intricacies of testosterone replacement therapy, and the crucial question of who should and shouldn't explore this avenue. Scott Howell, Ph.D., is the research director and primary investigator of Tier 1 Center for Clinical Research. He is an epidemiologist and exercise physiologist with research interests in the long-term safety of therapeutic androgen use, endocrine disrupting chemicals exposure, and preventative medicine. His work has been frequently published in notable...

Scott Howell, Ph.D., is the research director and primary investigator of Tier 1 Center for Clinical Research. He is an epidemiologist and exercise physiologist with research interests in the long-term safety of therapeutic androgen use, endocrine disrupting chemicals exposure, and preventative medicine. His work has been frequently published in notable peer-review journals including the American Journal of Physiology-Endocrinology and Metabolism and the Yale Journal of Biology and Medicine.

Our discussion touches on making informed decisions about aromatase inhibitors and finasteride – the estrogen and DHT blockers, respectively. Dr. Howell also sheds light on the potential negative pathways of testosterone and offers valuable insights into navigating these aspects.

Plus… we reveal some shocking facts about endocrine disruptors and their impact on the hormonal health of our species.

– About Muscle Intelligence –

We are raising the standard of men in their prime by helping aspirational men optimize their health so they can live longer, lead from the front and perform at their best everyday.

Learn more: muscleintelligence.com/mipapply

Support our Sponsors: